Home Bile-acid levels and lung maturity test in patients with intrahepatic cholestasis of pregnancy
Article
Licensed
Unlicensed Requires Authentication

Bile-acid levels and lung maturity test in patients with intrahepatic cholestasis of pregnancy

  • Itamar D. Futterman ORCID logo EMAIL logo , Howard Minkoff , Gladys Lee-Hwang and Jonathan C. Mays
Published/Copyright: June 20, 2022

Abstract

Objectives

Prolonged fetal exposure to maternal bile acids have been linked to fetal lung injury, but it is not known if it affects production of surfactant or fetal lung maturity tests. We set out to determine if elevated total bile acid (TBA) levels predict delayed fetal lung maturity (FLM) in patients with intrahepatic cholestasis of pregnancy (ICP).

Methods

A retrospective cohort study examining patients with ICP who underwent amniocentesis between 36+0 and 37+6 between 2005 and 2014. Primary goal was to identify if a relationship exists between TBA levels and FLM defined as Lecithin:Sphingomyelin >2.5, detectable Phosphatidylglycerol, or lamellar body count of >50,000.

Results

Among the 113 patients, there was no statistically significant difference in TBA levels between women with FLM and those with immaturity (31.3 [21.6, 44.5] μmol/L and 34.9 [23.9, 62.3] μmol/L respectively; p=0.16). Logistic regression performed using predefined TBA levels of 20, 30, 40 and 50 μmol/L revealed that TBA levels did not predict a negative FLM test at time of amniocentesis.

Conclusions

TBA levels do no predict presence or absence of FLM between 36+0 and 37+6 weeks of gestation. Though certain pregnancy complications can affect FLM, we could not identify a correlation between TBA levels and an accelerated or delayed lung maturation process.


Corresponding author: Itamar Futterman, Department of OBGYN, New York Medical College, Valhalla, NY, USA; Department of OBGYN, New York Health + Hospital/Metropolitan Hospital, New York, NY, USA; and Department of OBGYN, Division of Maternal Fetal Medicine, Maimonides Medical Center, 967 48th Street, Brooklyn, NY, 11219, USA, E-mail: , Phone: 917-992-0515

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Williamson, C, Geenes, V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014;124:120–33.10.1097/AOG.0000000000000346Search in Google Scholar PubMed

2. Zecca, E, De Luca, D, Marras, M, Caruso, A, Bernardini, T, Romagnoli, C. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics 2006;117:1669–72. https://doi.org/10.1542/peds.2005-1801.Search in Google Scholar PubMed

3. Yu, L, Ding, Y, Huang, T, Huang, X. Effect of bile acid on fetal lung in rat model of intrahepatic cholestasis of pregnancy. Int J Endocrinol 2014;2014:308274. https://doi.org/10.1155/2014/308274.Search in Google Scholar PubMed PubMed Central

4. Mays, JK. The active management of intrahepatic cholestasis of pregnancy. Curr Opin Obstet Gynecol 2010;22:100–3. https://doi.org/10.1097/GCO.0b013e328337238d.Search in Google Scholar PubMed

5. Roncaglia, N, Arreghini, A, Locatelli, A, Bellini, P, Andreotti, C, Ghidini, A. Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 2002;100:167–70. https://doi.org/10.1016/s0301-2115(01)00463-8.Search in Google Scholar PubMed

6. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, lee RH, mara greenberg, metz TD, pettker CM. Society for maternal-fetal medicine consult series #53: intrahepatic cholestasis of pregnancy: replaces consult #13, April 2011. Am J Obstet Gynecol 2021;224:B2–9. https://doi.org/10.1016/j.ajog.2020.11.002.Search in Google Scholar PubMed

7. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Reddy UM, Deshmukh U, Dude A, Harper L, Osmundson SS. Society for maternal-fetal medicine consult series #58: use of antenatal corticosteroids for individuals at risk for late preterm delivery: replaces SMFM statement #4, implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery August 2016. Am J Obstet Gynecol 2021;225:B36–42. https://doi.org/10.1016/j.ajog.2021.07.023.Search in Google Scholar PubMed

Received: 2022-02-12
Accepted: 2022-05-28
Published Online: 2022-06-20
Published in Print: 2022-11-25

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Obstetric hemorrhage: effective methods for addressing the menace in Sub-Saharan Africa
  4. Mini Review
  5. The use of neurally-adjusted ventilatory assist (NAVA) for infants with congenital diaphragmatic hernia (CDH)
  6. Opinion Paper
  7. The role of specialist perinatal psychiatrists in modern medicine
  8. Corner of Academy
  9. Maternal perception of fetal movements: onset and associated factors
  10. Original Articles – Obstetrics
  11. Cervical ripening as an outpatient procedure in the pandemic – minimizing the inpatient days and lowering the socioeconomic costs
  12. Can sonographic imaging of the fetal pancreas predict perinatal outcomes in gestational diabetes mellitus?
  13. Comparison of transvaginal sonographic cervical length measurement and Bishop score for predicting labour induction outcomes
  14. Regional differences in utilization of 17α-hydroxyprogesterone caproate (17-OHP)
  15. Effect of anesthesia selection on neonatal outcomes in cesarean hysterectomies for placenta accreta spectrum (PAS)
  16. Bile-acid levels and lung maturity test in patients with intrahepatic cholestasis of pregnancy
  17. Evaluation of appropriate vancomycin prescribing for the prevention of newborn group B streptococcal infections in a community hospital obstetrics service
  18. Effect of supplementation with 5,000 IU of vitamin D on the glycemic profile of women with gestational diabetes mellitus
  19. Association of methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms with vitamin B12 deficiency and adverse perinatal outcomes among pregnant women of rural South India – a cross sectional longitudinal study
  20. Original Article – Fetus
  21. Fetal autopsy for the diagnosis of skeletal dysplasia and comparison with prenatal ultrasound findings over a 16-year period
  22. Original Articles – Neonates
  23. Neonatal admission rate after vaginal breech delivery
  24. Extremely low gestational age neonates and resuscitation: survey on perspectives of Canadian neonatologists
  25. The effect of 150 and 80 mg doses of aspirin on preventing preterm birth in high-risk pregnant women
  26. Letters to the Editor
  27. Aspirin for the prevention of preeclampsia
  28. Reply to: Aspirin for the prevention of preeclampsia
  29. Total bile acid levels for clinically suspected intrahepatic cholestasis of pregnancy
  30. Reply: Neonatal lung injury with intrahepatic cholestasis of pregnancy
  31. Marijuana and pregnancy: just because its legal doesn’t make it safe
  32. Corrigenda
  33. Stillbirth aftercare in a tertiary obstetric center–parents’ experiences
  34. Prospective risk of stillbirth according to fetal size at term
Downloaded on 29.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2022-0085/html
Scroll to top button